We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.33B
AUM Growth
+$70.1M
Cap. Flow
-$89.7M
Cap. Flow %
-3.85%
Top 10 Hldgs %
23.05%
Holding
203
New
5
Increased
30
Reduced
65
Closed
11

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$12.8M
2
IQV icon
IQVIA
IQV
+$8.32M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.79M
4
POOL icon
Pool Corp
POOL
+$7.16M
5
DVN icon
Devon Energy
DVN
+$6.82M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$29.3M
2
ACGL icon
Arch Capital
ACGL
+$24.2M
3
NEE icon
NextEra Energy
NEE
+$11.7M
4
FISV
Fiserv Inc
FISV
+$8.96M
5
ECL icon
Ecolab
ECL
+$6.6M

Sector Composition

Rank Sector Weight
1 Technology 33.52%
2 Industrials 18.51%
3 Financials 15.9%
4 Healthcare 15.48%
5 Consumer Discretionary 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMS icon
151
Maximus
MMS
$3.17B
$2.63M 0.11%
35,900
– –
C icon
152
Citigroup
C
$222B
$2.62M 0.11%
58,000
-9,000
-13% -$409K
COIN icon
153
Coinbase
COIN
$38.6B
$2.62M 0.11%
74,000
-11,000
-13% -$580K
HELE icon
154
Helen of Troy
HELE
$644M
$2.55M 0.11%
23,000
– –
QLYS icon
155
Qualys
QLYS
$5.1B
$2.44M 0.1%
21,700
– –
SIGI icon
156
Selective Insurance
SIGI
$5.65B
$2.42M 0.1%
27,300
– –
ICPT
157
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.41M 0.1%
195,000
-200,000
-51% -$2.83M
KAI icon
158
Kadant
KAI
$3.63B
$2.4M 0.1%
13,500
– –
HCSG icon
159
Healthcare Services Group
HCSG
$1.6B
$2.39M 0.1%
198,800
– –
MTN icon
160
Vail Resorts
MTN
$5.32B
$2.38M 0.1%
10,000
– –
STZ icon
161
Constellation Brands
STZ
$22.2B
$2.32M 0.1%
10,000
– –
MRCY icon
162
Mercury Systems
MRCY
$5.83B
$2.25M 0.1%
50,300
– –
LCII icon
163
LCI Industries
LCII
$2.49B
$2.22M 0.1%
24,000
– –
VC icon
164
Visteon
VC
$2.79B
$2.16M 0.09%
16,500
– –
MU icon
165
Micron Technology
MU
$930B
$2.1M 0.09%
42,000
-65,015
-61% -$3.56M
CNXC icon
166
Concentrix
CNXC
$1.5B
$2.09M 0.09%
15,700
– –
GH icon
167
Guardant Health
GH
$21.7B
$2.04M 0.09%
+75,000
New +$3.43M
SNX icon
168
TD Synnex
SNX
$20.4B
$2.03M 0.09%
21,400
– –
LFUS icon
169
Littelfuse
LFUS
$11.2B
$2.03M 0.09%
9,200
– –
GNRC icon
170
Generac Holdings
GNRC
$11.6B
$2.01M 0.09%
20,000
– –
CNMD icon
171
CONMED
CNMD
$1.39B
$2.01M 0.09%
22,700
– –
LYFT icon
172
Lyft
LYFT
$6.02B
$1.98M 0.09%
180,000
-150,000
-45% -$1.81M
FELE icon
173
Franklin Electric
FELE
$4.63B
$1.94M 0.08%
24,341
+4,200
+21% +$347K
IRTC icon
174
iRhythm Holdings
IRTC
$3.85B
$1.9M 0.08%
20,300
– –
PTON icon
175
Peloton Interactive
PTON
$2.77B
$1.87M 0.08%
235,000
-225,000
-49% -$2.16M
5 6
7
8 9

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, EULAV Asset Management held 203 positions worth $2.33B, up 3.1% from $2.26B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

EULAV Asset Management withdrew a net $89.7M in Q4 2022, closing 11 positions and reducing 65 holdings. Its most notable exit was Arch Capital, an estimated $24.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Industrials and Financials.

Against the trend, EULAV Asset Management opened a new position in BioMarin Pharmaceuticals worth $8.59M.

  • EULAV Asset Management's largest Q4 2022 buy was BioMarin Pharmaceuticals: 83,000 shares worth $8.59M.
  • EULAV Asset Management added most to Idexx Laboratories in Q4 2022, an estimated $12.8M increase.
  • EULAV Asset Management's biggest Q4 2022 reduction was Danaher, cutting an estimated $29.3M.
  • EULAV Asset Management fully exited Arch Capital in Q4 2022, selling an estimated $24.2M.
  • EULAV Asset Management's ten largest holdings make up 23% of its $2.33B portfolio in Q4 2022.
  • EULAV Asset Management opened 5 new positions and closed 11 in Q4 2022.
  • EULAV Asset Management's portfolio value rose 3.1% quarter-over-quarter to $2.33B.

Based on EULAV Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.